CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 84 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2018. The put-call ratio across all filers is 3.04 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $907,000 | -76.8% | 108,061 | -85.5% | 0.26% | -84.0% |
| Q1 2020 | $3,916,000 | +141.3% | 747,300 | +151.4% | 1.63% | +193.4% |
| Q4 2019 | $1,623,000 | +12.1% | 297,300 | 0.0% | 0.56% | +2.2% |
| Q3 2019 | $1,448,000 | -29.7% | 297,300 | 0.0% | 0.54% | -29.6% |
| Q2 2019 | $2,060,000 | -2.8% | 297,300 | -2.5% | 0.77% | -15.4% |
| Q1 2019 | $2,120,000 | +134.3% | 305,000 | +96.8% | 0.92% | +103.3% |
| Q4 2018 | $905,000 | -24.3% | 155,000 | -61.2% | 0.45% | -52.5% |
| Q2 2016 | $1,196,000 | +1413.9% | 400,000 | +700.0% | 0.95% | +1115.4% |
| Q3 2015 | $79,000 | -30.1% | 50,000 | +36.6% | 0.08% | -18.8% |
| Q2 2015 | $113,000 | – | 36,590 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 3,738,925 | $23,555,000 | 31.22% |
| Perceptive Advisors | 1,232,500 | $7,764,000 | 0.39% |
| IFP Advisors, Inc | 1,001,025 | $6,306,000 | 0.27% |
| WOODSTOCK CORP | 55,489 | $350,000 | 0.07% |
| Virtus ETF Advisers LLC | 50,795 | $320,000 | 0.05% |
| Dynamic Technology Lab Private Ltd | 31,431 | $198,000 | 0.04% |
| Evanson Asset Management, LLC | 20,660 | $130,000 | 0.03% |
| Artal Group S.A. | 250,000 | $1,575,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 58,800 | $370,000 | 0.02% |
| Raymond James Financial Services Advisors, Inc. | 426,280 | $2,686,000 | 0.02% |